Clinical Endpoint Adjudication: Strategies to Improve CEC Process Flow and Accurate Endpoint Review

Publish Date:
December 11, 2015
Lisa Moore, PhD, RN, Senior Director, Scientific Affairs, Chiltern, Richard H. Patt, MD, Principal and Cofounder, RadMD and BRITI

Endpoint and event adjudication brings scientific rigor to a complex trial and is frequently requested by regulatory authorities. The use of adjudication committees is becoming commonplace across many indications and study phases and frequently involves imaging endpoints. Most often, these are trials with cardiovascular or composite endpoints. Successful adjudication requires careful and early planning from all key stakeholders in the process. In this presentation, you will learn how to run a successful clinical endpoint committee (CEC), mitigate risks to adjudication and put the best processes in place to save time and costs.